Cargando…
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
Mutations in USH2A are among the most common causes of syndromic and non-syndromic retinitis pigmentosa (RP). The two most recurrent mutations in USH2A, c.2299delG and c.2276G > T, both reside in exon 13. Skipping exon 13 from the USH2A transcript presents a potential treatment modality in which...
Autores principales: | Dulla, Kalyan, Slijkerman, Ralph, van Diepen, Hester C., Albert, Silvia, Dona, Margo, Beumer, Wouter, Turunen, Janne J., Chan, Hee Lam, Schulkens, Iris A., Vorthoren, Lars, den Besten, Cathaline, Buil, Levi, Schmidt, Iris, Miao, Jiayi, Venselaar, Hanka, Zang, Jingjing, Neuhauss, Stephan C.F., Peters, Theo, Broekman, Sanne, Pennings, Ronald, Kremer, Hannie, Platenburg, Gerard, Adamson, Peter, de Vrieze, Erik, van Wijk, Erwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353187/ https://www.ncbi.nlm.nih.gov/pubmed/33895329 http://dx.doi.org/10.1016/j.ymthe.2021.04.024 |
Ejemplares similares
-
A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa
por: Schellens, Renske T.W., et al.
Publicado: (2023) -
Molecular Inversion Probe-Based Sequencing of USH2A Exons and Splice Sites as a Cost-Effective Screening Tool in USH2 and arRP Cases
por: Reurink, Janine, et al.
Publicado: (2021) -
Scrutinizing pathogenicity of the USH2A c.2276 G > T; p.(Cys759Phe) variant
por: Reurink, Janine, et al.
Publicado: (2022) -
Clinical and preclinical therapeutic outcome metrics for USH2A-related disease
por: Toms, Maria, et al.
Publicado: (2020) -
Eyes shut homolog is important for the maintenance of photoreceptor morphology and visual function in zebrafish
por: Messchaert, Muriël, et al.
Publicado: (2018)